Navigation Links
Matthew Sarad to Reverse Aging and Cure Cancer
Date:9/11/2009

ases, such as macular degeneration, arteriosclerosis, osteoporosis, and other degenerative diseases that might be reversed by restoring telomere length.

According to Mr. Sarad, "This experiment is incredibly important. I think we now have a mixture of nanotechnology based gene therapy products that can result in what might be called significant 'organismal rejuvenation'. We have seen regeneration of human tissues in the laboratory. How far this technology can ultimately go is hard to say, but I am optimistic that this is the first step in what will be referred to historically as the moment the age-barrier was broken."

This research may also change the way that cancer is treated in the future. For example, Mr. Sarad's company licensed and improved a protein based anti-cancer therapeutic noted in studies by the University of Nebraska Medical Center to be non-toxic and to cause long-term remission in 80% of all cancer, including difficult to treat neuronal cancer. The Corporation was working on increasing the remission rate further by delivering other tumor suppressor proteins. One or more tumor suppressor genes is corrupted, silenced, or deleted in almost all cancer. This therapeutic drug is being studied today at the country's third largest hospital the Cleveland Clinic in the treatment of cancer and restenosis. The hospital is also studying some of the corporation's tissue regeneration technologies.

Mr. Sarad's career in biotechnology has not been without controversy. In 2008 he was sanctioned by the SEC for alleged securities violations made while taking his company public in 2006. The company, Telomolecular Corp., achieved public status but its shares were later deregistered.

"The mistake I made was being young, inexperienced, and excited about the prospects of our technologies," said Mr. Sarad. "I failed to disclose that our management was inexperienced engineering an IPO and this may have been mislea
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

3

GOOD

Page: 1 2 3 4

Related biology technology :

1. Genstructs Andrea Matthews Selected for Mass High Techs People to Watch Under 30
2. Cerimon Pharmaceuticals Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing
3. Cord Blood America CEO Matthew Schissler Interviewed by BIONOVA, Greeces Leading Biotech Magazine
4. Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales
5. Neurobiological Technologies Appoints Matthew M. Loar as Chief Financial Officer
6. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
7. Cord Blood America CEO Matthew Schissler Says Operations Significantly Streamlined
8. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
9. Matthew B. Wiener, CEO of Pharmatech, Inc., Is Awarded the Cancer Leadership Award From the Colorado Cancer Coalition
10. USP Names Matthew Heyman Vice President of External Affairs and Strategic Integration
11. Matthew Lehman of SPRI Clinical Trials Speaks On Designing Trials For Success At The Trout Group Investor Relations Seminar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... ALBANY, New York , May 21, 2013 /PRNewswire/ ... published by Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip ... Science Research, IVD Tests) - U.S. Industry Analysis, Size, Share, ... USD 2.4 billion in 2011 and is expected to ... 2018, to reach an estimated value of USD 4.7 ...
(Date:5/21/2013)... Biologics, Inc. (NYSE MKT: SYN), a developer of biologics focused ... today that Jeffrey Riley , CEO, will ... Conference on Thursday, May 30, 2013 in New ... Riley is scheduled to present at 10:00 a.m. (Eastern Time). ... be accessed by logging onto the web at http://wsw.com/webcast/marcum/syn/ ...
(Date:5/21/2013)... Mississauga, Ontario (PRWEB) May 21, 2013 ... expert scientists of the ITN to design the ... usefulness of two key clinical models used in ... Chamber (EEC) and Nasal Allergen Challenge (NAC) models. ... supported by numerous publications, to date no direct ...
(Date:5/21/2013)... May 21, 2013 The Formulate Fusion ... solution for sales and marketing teams looking for a fully-functional ... the kit as “everything you’ll need to put together a ... Kit comes with a number of displays and accessories that ... 20 feet by 20 feet in size. These components vary ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2
... Society of Chemical Manufacturers and Affiliates (SOCMA) ... new affiliate group that aims to advance the commercialization ... for the production and processing of chemicals, pharmaceuticals, materials ... to by its acronym, which stands for the Society ...
... Inc. (OTC Pink: DYAI), a global biotechnology company, today ... the first quarter ended March 31, 2012 after market ... a conference call at 5:00 p.m. Eastern Time to ... ) Those wishing to participate in ...
... ALBANY, N.Y., April 24, 2012 AMRI (NASDAQ: ... Business Development and Marketing functions. (Logo: ... American Discovery and Development teams are being combined into ... Conway, who has been promoted to Vice President, Business ...
Cached Biology Technology:SOCMA Announces Launch of SCD-iBIO Group 2AMRI Strengthens Business Development and Marketing Groups 2AMRI Strengthens Business Development and Marketing Groups 3
(Date:5/21/2013)... increasingly being considered in the management of natural ... that can help them recognize and respond to ... their lives. , Place-Based Conservation: Perspectives from ... the Pacific Northwest Research Station,s Linda Kruger, can ... The book is published by Springer Verlag and ...
(Date:5/21/2013)... body, stem cells in the blood often jump ... immune cells that can fight off illness. But ... populations, potentially leading to the development of serious ... of researchers led by biologists at the California ... mouse models, the molecule microRNA-146a (miR-146a) acts as ...
(Date:5/21/2013)... new method for delivering molecules into single, targeted ... The technique could find applications in drug delivery, ... electroporation a technique used to deliver molecules ... membrane that are caused by exposing them to ... of cell transfection. (Cell transfection is the introduction ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Single-cell transfection tool enables added control for biological studies 2
... to plants for reasons that go beyond pollination, according ... issue of Current Biology , a Cell Press ... caterpillars that would otherwise munch on them undisturbed. ... Wrzburg, Germany, earlier found that many caterpillars possess fine ...
... HOUSTON, Dec. 22, 2008 B. Montgomery "Monte" Pettitt, the ... Professor of Physics, Computer Science, Biology and Biochemistry at the ... from the American Association for the Advancement of Science (AAAS). ... among Texas, 16 honorees, six of whom are from Houston ...
... been awarded the distinction of Fellow in the American ... the field of microbial genomics and ecology, particularly for ... Election as a Fellow is an honor ... a presidential professor in OU,s Department of Botany and ...
Cached Biology News:Honeybees as plant 'bodyguards' 2Chemistry professor 1 of only 3 at UH to achieve prestigious AAAS status 2University of Oklahoma researcher named 2008 AAAS Fellow 2
... peptides are molecules of peptidic nature or ... activity which can be developed at the ... agro-food applications. In this way it is ... properties for therapeutic applications. Primm offers a ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Material: ...
... forced convection Temperature range 5 C / ... / 212 F Patented APT.line preheating chamber ... controller Timer 0 to 24 h ... tenth of a degree Independent adjustable temperature ...
... Maximize the value of your microarray ... offer the support you need from ... the most up to date methods. ... the Gene Expression Profiling Service or ...
Biology Products: